gms | German Medical Science

68. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie (DGNC)
7. Joint Meeting mit der Britischen Gesellschaft für Neurochirurgie (SBNS)

Deutsche Gesellschaft für Neurochirurgie (DGNC) e. V.

14. - 17. Mai 2017, Magdeburg

Artikel

Artikel empfehlen

Repurposing of the old sulfone antibiotic dapsone for the treatment of gliomas

Meeting Abstract

Suche in Medline nach

  • Georg Karpel-Massler - Neurochirurgische Klinik der Universität Ulm, Ulm, Deutschland
  • Richard Kast - IIAIGC, Burlington, VT, United States
  • Xiao Yun Chen - Jiangsu University of Science and Technology, Zhenjiang City, Jiangsu, China
  • Christian Rainer Wirtz - Bezirkskrankenhaus Günzburg, Neurochirurgische Klinik der Universität Ulm, Günzburg, Deutschland
  • Marc-Eric Halatsch - Neurochirurgische Klinik der Universität Ulm, Ulm, Deutschland
  • Carsten Bolm - Institut für organische Chemie der Universität Aachen, Aachen, Deutschland

Deutsche Gesellschaft für Neurochirurgie. Society of British Neurological Surgeons. 68. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie (DGNC), 7. Joint Meeting mit der Society of British Neurological Surgeons (SBNS). Magdeburg, 14.-17.05.2017. Düsseldorf: German Medical Science GMS Publishing House; 2017. DocP 033

doi: 10.3205/17dgnc596, urn:nbn:de:0183-17dgnc5966

Veröffentlicht: 9. Juni 2017

© 2017 Karpel-Massler et al.
Dieser Artikel ist ein Open-Access-Artikel und steht unter den Lizenzbedingungen der Creative Commons Attribution 4.0 License (Namensnennung). Lizenz-Angaben siehe http://creativecommons.org/licenses/by/4.0/.

Gliederung

Text

Objective: Dapsone is an antibiotic used for the treatment of mycobacterial and protozoal infections. We previously hypothesized that dapsone could possess biological activity extending beyond its anti-infectious properties and that it potentially represents a candidate for repurposing in the setting of glioma therapy.

Methods: Established glioblastoma cell lines and primary cultured glioma cells were treated with dapsone or several different chemical analogues of dapsone which we previously synthesized (D2-D5) and examined effects on proliferation, anchorage-independent growth and migration.

Results: Dapsone and its synthetic analogues D2-D5 displayed only modest anti-proliferative activity. However, treatment with dapsone lead to a significant inhibition of important neoplastic features such as anchorage-independent growth and directed migration. Moreover, several dapsone analogues yielded even enhanced anti-glioma activity.

Conclusion: Dapsone has pronounced activity against glioma which can be further enhanced by its molecular modification. Overall, dapsone holds strong promise to serve as a supplementary therapeutic measure for glioma therapy in a repurposing approach.